debt cap
valu usd unless otherwis note
solid print portend well earn
view anoth impress perform ep top
expect strong revenu earn growth across busi
line contrari last quarter mcr concern caus sell-off
beat-and-rais along messag strong momentum
enough send stock higher rais price target
base adj ep
take-away deliv solid beat-and-rais reflect
strong broad-bas top-line growth acceler vs declin
mcr time around perform much better receiv
last quarter also like reflect better mcr
strong momentum head tailwind includ continu
strength medicaid commerci segment uhc
advanc optum busi line expans global capit
deploy far outweigh headwind larg
industry-rel formal guidanc expect investor day
balanc remain posit rais price target
adj ep vs consensu result
line acceler vs along lower mcr despit less
impress growth continu revenu
plan year market remain competit uhc optimist
product offer servic area
compar plan member
project see yoy increas reduct premium uhc plan
continu outpac industri growth manag estim
long term
medic cost trend remain consist expect date cost
growth trend slightli vs primarili
driven unit cost growth vs util pharmaci inpati
toward low end rang
strong sell season optumrx solid new win
exceed impress retent third
consecut year recent specialti pharmaci acquisit behavior
oncolog care highlight compani pivot pbm
momentum clearli strong head tailwind
surpass larg industry-wid headwind earn growth
expect consist compani target
long term manag note current consensu captur
intern outlook within typic size rang formal guidanc
expect novemb investor day
price prior trade day market close estimate unless otherwis note
expect share outperform sector
enterpris signific breadth
servic offer popul serv
compani continu innov order remain
center healthcar healthcar chang posit
well benefit virtual new direct healthcar
unit market leader virtual everi busi segment
oper continu exceed market growth
rate leverag signific scalabl
compani optum segment uniqu competit
differenti provid diversif revenu
earn stream well posit capit futur
chang healthcar payor-agnost way
visibl remain good broad-bas growth
across differenti busi line continu strong
perform cost care oper expens
gener remain strong clear
demonstr solid balanc sheet remain top
bloomberg capit market estim upside/downside/target
price target previous base price-to-earnings
multipl adjust ep previous
estim believ premium valuat rel
group warrant continu execut oper
lead earn estim beat rais consist
compani histori howev note target
multipl still repres discount histor
peak valuat level approxim provid
upsid scenario gener valu upsid
scenario assum price-to-earnings estim assum
high end manag long-term ep growth target
upsid scenario target multipl consist
downsid scenario gener share valuat
valu downsid scenario assum
ep come approxim estim
assum price-to-earnings multipl declin
downsid scenario earn consist
valuat multipl low seen past coupl year
saw financi momentum acceler report adjust ep
vs estim consensu result reflect continu solid
growth across compani diversifi busi line acceler vs along
mcr improv despit less favor prior-period develop medic cost trend
remain consist expect adjust ep outlook rais reflect
solid year-to-d perform maintain prudent approach medic cost
trend go forward increas growth invest year-end
consolid revenu increas yoy reflect impress
growth optum uhc benefit segment acceler rel
includ contribut recent acquisit consolid oper incom grew
approxim yoy solid oper margin flat yoy
net margin bp yoy uhc consolid medic care ratio declin bp
yoy come low end guidanc nice improv
rel high end rang improv came despit less favor
medic reserv develop incl favor
unfavor vs continu impact mix chang
toward higher-mcr product off-set impact hif return
mcr declin partli off-set yoy increas consolid oper cost
ratio vs guidanc reflect hif return impact partli off-set
mix shift toward lower-opex busi oper cost effici medic cost trend
remain consist expect vs guidanc
primarili driven unit cost growth vs util pharmaci inpati come
lower end rang continu approxim nine year declin inpati
healthcar healthcar oper oper net oper cost payabl net claim healthcar facil servic
full guidanc come annual investor day novemb momentum clearli strong
head earn growth expect consist compani target
long term manag note current consensu ep
captur intern outlook within typic size rang specif consider head
next year includ
continu solid top-line growth uhc uhc post revenu growth approxim
approxim reflect contribut banmedica acquisit
close impact hif return growth membership higher-acu
busi mix total medic membership increas yoy
includ growth sequenti basi
oper incom uhc increas solid yoy margin declin
bp previous note consolid mcr declin bp yoy
declin relat hif return offset impact mix shift toward higher-
mcr busi declin favor pyd howev mcr declin off-set
higher opex
uhc continu pursu greater orient toward valu volum servic
effort includ direct increas amount spend toward value-bas construct well
migrat spend toward manag health popul oppos
individu qualiti metric uhc current approxim value-bas
construct half total medical/surg spend exce previou
goal earlier expect manag target
within value-bas construct half amount progress
relationship orient around popul outcom five year ago
separ year-end target develop individu health record
full-benefit peopl serv across platform use ralli chassi
tailwinds- strong year expect ma- strong year expect commerci np employ advancing- nation account aso book pivot growth medicaid continu perform well dual improv seen- strong momentum optumrx success sell season- optumcar enter new markets- optuminsight perform well cost containment- global busi continu expand benefit care delivery- continu capit deploymentheadwind larg industry-rel deep concern medic cost need price conservatively- suffici govern fund need deliv valu members- pace invest np valu company- specif growth invest incl new market commerci expand optumcare- hif return must built premium neg impact np note impact net tax reform benefit half estim healthcar facil servic
exhibit unitedhealthcar revenu segment million
impress top-line growth aid acquisit uhc medicar retir
busi segment revenu post impress revenu growth yoy
membership increas yoy includ ad
peopl health acquisit louisiana state highest star-rat plan quarter
recal strong growth membership uhc experienc higher mcr
book front end compani coordin care program take effect cost
stabil begin benefit mcr
manag note approxim save averag cost care plan
rel tradit medicar market much plan
year market remain competit uhc optimist product offer
compar plan peopl choic uhc product
member project see yoy increas reduct
premium manag continu view long-term market growth vs
cmss project uhc plan continu outpac industri
last year
employ individu segment revenu increas yoy impact
hif return continu growth risk-bas membership partli off-set aso
membership loss expect total commerci membership declin yoy
exclud tricar risk-bas product continu perform well yoy
partli off-set declin fee-bas aso product
manag expect enrol declin self-fund portion
nation account segment continu strong perform middle-market
segment client employe larg win public sector
expect modest growth self-fund market overal
commun state continu strong top-line growth yoy reflect solid
enrol growth particularli toward member higher clinic need includ
dual-elig long-term servic support program medicaid enrol increas
yoy sequenti due divestitur new
mexico plan member partli off-set organ growth member
global segment revenu yoy uhc total revenu
manag attribut busi expans membership intern plan increas
yoy sequenti larg reflect banmedica acquisit
ad member south america compani continu see improv clinic
financi perform hospit brazil
advantag supplement medicar govern aso medic part healthcar facil servic
optum impress momentum continu top-line growth acceler optum
post double-digit earn growth across three busi segment total revenu
growth acceler yoy oper incom
margin increas bp yoy
exhibit optum revenu segment million
optumrx pbm servic top-line growth driven primarili mix revenu increas
yoy includ growth adjust script volum along
continu benefit growth specialti pharmaci home deliveri mix manag
expect anoth strong year retent approxim sell season
announc earlier year optumrx appli manufactur rebat point sale
fulli insur member begin expect minim direct
financi impact compani manag note posit reaction consum
broker improv transpar pbm sell season wrap
optumrx seen yoy growth client sold vs season includ good state
win new health plan win larg employ win well strong retent
higher third consecut year
recent acquisit enhanc compani specialti pharmaci capabl
uniqu offer behavior genoa healthcar oncolog care avella manag
note optumrx readi whatev evolut may take place pharmaci
marketplac compani pivot pbm pharmaci care servic busi
optumhealth care deliveri care manag consum engag distribut
health financi servic solid top-line growth increas reflect yoy
growth number consum serv flat sequenti compani
continu develop care deliveri busi optumcar provid primari care
peopl yoy market serv health plan howev manag
note mani local market effort still earli invest stage
compani continu build high-perform ambulatori care system next
decad davita medic group acquisit add employ
affili physician serv patient annual remain track close year-end
optuminsight oper servic support health servic busi revenu
yoy increas driven larg reflect steadi growth data analyt
expans busi process advisori servic care provid well
acquisit advisori board compani healthcar busi optuminsight
backlog continu grow yoy anoth record high manag
see meaning opportun develop care provid servic capabl
continu strong cash flow fund buyback dividend increas
end quarter cash short-term invest long-
term invest total debt repres total capit
adjust cfop normal time premium payment declin approxim
yoy repres approxim net incom day claim payabl
increas three day sequenti day flat yoy repurchas
share quarter ytd bought back share
paid dividend increas dividend
guidanc rais
manag increas adjust ep guidanc approach
previou rang midpoint exce amount
beat rais adjust ep consist revis
guidanc repres yoy growth
consist long-term target
million except per share membership data lowhighlowhighlowhighlowhighlowhighunitedhealthcar revenu outlook employ individu unitedhealthcar oper oper medic membership outlook commerci part membership yoy commerci risk-bas -- medicar million except per share membership data lowhighoptum revenu optum oper oper oper oper oper oper oper oper consum serv revenu per consum revenu backlog backlog averag monthsoptumrx adjust script oper oper care cost earn dilut epsapproach dilut epsapproach flow operationsapproach healthcar facil servic
price target base price-to-earnings multipl adjust ep
believ premium valuat rel group warrant continu execut
oper lead earn estim beat rais consist compani
histori howev note target multipl still repres discount
histor peak valuat level approxim provid conservat
price target support outperform rate
risk rate price target
execut risk predict manag medic cost trend
execut risk network contract
reimburs risk govern busi
unitedhealth group incorpor oper diversifi health well-b compani
unit state compani unitedhealthcar segment offer consumer-ori
health benefit plan servic nation employ public sector employ mid-
size employ small busi individu healthcar coverag health
well-b servic individu age older address need prevent
acut healthcar servic also provid servic deal chronic diseas
special issu older individu medicaid plan children insur
program health care program health servic includ commerci health
deliveri care manag consum engag distribut health financi servic
segment serv individu program offer employ payor govern
entiti directli care deliveri system compani optuminsight segment
provid softwar inform product advisori consult servic busi
process outsourc servic hospit physician commerci health plan govern
agenc life scienc compani organ optumrx segment offer
pharmaci benefit manag servic program includ retail pharmaci network
manag home deliveri specialti pharmaci manufactur rebat contract
administr benefit plan design consult claim process rang clinic
program servic formulari manag complianc drug util review
diseas drug therapi manag servic compani found
base minnetonka minnesota
million except per share data
product sold
provis tax
net incom nci
earn attrib non-controlling interest
net incom attibut common share
oper cost ratio
